FindTrial
Sign In

Role of B-Type Natriuretic Peptide in predicting in Hospital mortality and Length of stay of Acute Exacerbation of Chronic Obstructive Pulmonary Disease Cases with Normal Heart function

Predictive Value of B-Type Natriuretic Peptide in Outcome of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Preserved Left Ventricular Function - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/077810
Enrollment
90
Registered
2024-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J441- Chronic obstructive pulmonary disease with (acute) exacerbation

Interventions

Control Intervention1: NIL: NIL

Sponsors

Department of Critical Care Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of COPD with acute exacerbation

Exclusion criteria

Exclusion criteria: Known cases of cardiovascular disease, other chronic respiratory diseases such as asthma, interstitial lung diseaseand other chronic diseases like chronic kidney or liver diseases

Design outcomes

Primary

MeasureTime frame
Need of ventilation (Non invasive ,Invasive) in Different BNP groups.Timepoint: Day 1—

Secondary

MeasureTime frame
Length of Hospital stay and mortality in different BNP groups.Timepoint: 28 days—

Countries

India

Contacts

Public ContactDrRavi Prakash Yadav

IGIMS

Sanjeev_pranay71@hotmail.com9473191829

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026